Tuesday, 5th April 8th International Conference on Plasmodium vivax Research 2022

Please note, all times are listed in Australian Eastern Standard Time. 

Use a time zone converter to see your local time: https://www.timeanddate.com/worldclock/converter.html 

Chairs: Wai-Hong Tham & Ric Price

Models for P. vivax biology study: Recent Advances and the Gap - Prof Jetsumon (Sattabongkot) Prachumsri
The Pan African Vivax and Ovale Network (PAVON) in the paradigm shift for malaria elimination in sub-Saharan Africa - Prof Isaac Quaye

Panel Q&A - 15 minutes

WHO estimation of the global burden of P. vivax malaria: methods, limitations and future work - Abdisalan Noor

• How often does P. vivax infection and illness occur without parasitemia of peripheral blood? - J. Kevin Baird
• A mathematical model of hypnozoite accrual, multiple infections and acquired immunity for Plasmodium vivax - Somya Mehra
• Impact of a clinic-based “Malaria Corner” on health care delivery and recurrent episodes of malaria in Timika, Papua, Indonesia - Liony Fransisca

Panel Q&A - 15 minutes

• A spatio-temporal analysis of malaria cases in the Brazilian Amazon - Daniel AM Villela
• Utilization of positive malaria rapid diagnostic tests (mRDTs) for tracking, confirmation, speciation, and quantification by microscope examination in Zanzibar - Safia Mohammed SMA Ali
• Relapse vs. Recrudescence: What explains extraordinary recurrence rates of vivax malaria in Allied Prisoners of War in Asia during the Second World War? - G. Dennis Shanks
• Prolonged breastfeeding and risk of blood-stage Plasmodium vivax infection and clinical malaria in early childhood: population-based birth cohort study - Anaclara Pincelli
• The interplay of travel and seasonality on Plasmodium vivax and Plasmodium falciparum risk in the Ethiopian Highlands - Gustavo da Silva
• Understanding the occurrence of asymptomatic infections: the human and parasite influence - Caroline Jasmine Abanto Alvarez
• Parasite and Gametocyte Fluctuation of Plasmodium vivax in Belu District, East Nusa Tenggara, Indonesia - Ayleen AK Kosasih
• Plasmodium vivax in native communities of Amazonas, Peru between 2005 and 2020. - Angelica Vigil
• Malaria and Risk factors in symptomatic under five children - Ashenafi Abossie

• Significance of plasma Il-9, IP-10, MIP-b, PDGF-bb and RANTES levels in Asymptomatic malaria infection - KATHERINE TORRES
• Evaluating thrombocytopenia and Pvmsp3α in Plasmodium vivax clinical infections for disease severity. - Aditi Arya
• Humanized mouse models to study the in vivo role of extracellular vesicles in the bone marrow and spleen during vivax malaria - Iris Aparici-Herraiz
• Functional characterization of bone marrow and spleen-dependent P. vivax genes through CRISPR-Cas9 editing. - Alberto Ayllon-Hermida

Hidden biomass of vivax parasites in the spleen - Steven Kho

• Total parasite biomass but not peripheral parasitaemia is associated with host perturbations in Plasmodium vivax patients: the role of the hematopoietic parasite reservoir in Plasmodium vivax infection and pathology - Joao Luiz Silva-Filho
• Controlled Human Infection Reveals Parasite-Specific Immune Responses to P. vivax And P. falciparum - Florian Bach
• High dimensional single cell mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria - Lisa J Ioannidis

Panel Q&A - 15 minutes